安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors
- Package Insert - ADSTILADRIN
ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy designed to deliver a copy of a gene encoding a human interferon-alfa 2b (IFNα2b) to the bladder urothelium
- Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
Adstiladrin (nadofaragene firadenovec-vncg) is a prescription gene therapy used to treat certain adults with high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) It works by delivering the interferon alfa-2b gene into cells in the bladder wall
- Nadofaragene firadenovec - Wikipedia
Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer [1][3][4] It is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy
- Ferring announces full availability of ADSTILADRIN® (nadofaragene . . .
Approved by the U S Food Drug Administration (FDA) in December 2022, ADSTILADRIN is the first and only FDA-approved intravesical gene therapy for adults with NMIBC who no longer respond to standard therapy
- Treatment With ADSTILADRIN® (nadofaragene firadenovec-vncg)
Explore the treatment process with ADSTILADRIN, including how it is given, what patients can expect, and possible side effects See Important Safety Info
- U. S. FDA Approves Label Update to Accelerate Thaw Time for ADSTILADRIN . . .
ADSTILADRIN is the first and only FDA-approved non-replicating intravesical gene-therapy for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) with or without papillary tumors (±Ta T1)
- Adstiladrin Bladder Cancer Treatment - The Urology Group Virginia
Adstiladrin (nadofaragene firadenovec-vncg) is a medicine used to treat adults with a type of bladder cancer called high-risk non-muscle invasive bladder cancer (NMIBC) that has not responded to a treatment called BCG
|
|
|